DG Infants’ Acetaminophen

December 2021: The Court granted final approval of the settlement agreement.

September 2021: Plaintiffs moved for final approval of the settlement agreement.

May 2021: The Court granted preliminary approval of the settlement agreement.

February 2021: Plaintiffs moved for preliminary approval of a proposed settlement agreement.

September 2020: A class-action lawsuit was filed against Dollar General for allegedly misleading consumers by marketing its DG™ brand Infants’ Pain & Fever Acetaminophen and Children’s Pain & Fever Acetaminophen as different products in order to charge consumers more for the infants’ medication when, according to the complaint, both medicines contain the same amount of the active ingredient acetaminophen. (Levy et al. v. Dolgen Corp, LLC et al., Case No. 20-cv-1037, M.D. Fla.)

For more of TINA.org’s coverage of the marketing of acetaminophen products, click here.